Cargando…
Six-Month Outcomes of Heart Transplant Recipients Infected by COVID-19
PURPOSE: COVID-19 infection might be associated with higher mortality risk for transplanted patients, as a result of their multiple co-morbidities and their immunosuppressed status. We sought to describe the six-month outcomes of heart transplant (HT) recipients infected by COVID-19. METHODS: We ret...
Autores principales: | Diakos, N., Latif, F., Takeda, K., Clerkin, K., Habal, M., Naka, Y., Restaino, S., Oh, K., Sayer, G., Farr, M., Uriel, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979377/ http://dx.doi.org/10.1016/j.healun.2021.01.373 |
Ejemplares similares
-
Diagnostic et prise en charge de la fibrose post-COVID
por: Gader, N., et al.
Publicado: (2022) -
Cardiovascular Comorbidities and Covid-19 in Women
por: Weizman, O., et al.
Publicado: (2021) -
Remote Monitoring of Heart Transplant Recipients during the COVID-19 Pandemic
por: Slomovich, S., et al.
Publicado: (2021) -
Characteristics and Outcomes of Recipients of Heart Transplant with Coronarvirus Disease 2019 Who Received Casirivimab Plus Imdevimab Infusion
por: Gaine, M., et al.
Publicado: (2022) -
Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD
por: Oren, Daniel, et al.
Publicado: (2022)